| Source: |
| Type: |
| TRPV2 (transient receptor potential vanilloid 2) tends to be pro-tumor in many epithelial and metastatic contexts, but potentially anti-stemness / pro-differentiation in some brain tumor contexts. In prostate cancer, TRPV2 has been associated with migration, invasion markers, androgen-resistance progression, and metastatic disease. In gastric and esophageal cancers, higher TRPV2 has been linked to worse prognosis, and gastric studies suggest it can support PD-L1-related immune evasion. More recent breast cancer work also supports an oncogenic role, with TRPV2 promoting proliferation, migration, and invasion. |
| 5819- | CBD, | The potential role of cannabidiol (CBD) in lung cancer therapy: a systematic review of preclinical and clinical evidence |
| - | Review, | Lung, | NA |
| 5816- | CBD, | Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4 |
| - | in-vitro, | GBM, | NA |
| 5815- | CBD, | Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents |
| - | in-vitro, | GBM, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1458 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid